Score Overview
Explore the 2021 public Archive ranking →
Where Champions Oncology Inc has ranked, year by year
Showing 10 years ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- CSBR
2014: 89.9% · 2021: 50.6% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-10-01 | $ 4.88 | — |
1 Year2025-10-01 | $ 6.40 | -23.75% |
5 Years2021-10-01 | $ 9.96 | -51.00% |
10 Years2016-09-30 | $ 1.68 | 190.48% |
20 Years2006-09-25 | $ 0.01 | 325x |
30 Years1996-10-01 | $ 0.12 | 41x |
All Time2003-01-10 | $ 0.01 | 325x |
| Period | Last Price2026-10-01 | 1 Year2025-10-01 | 5 Years2021-10-01 | 10 Years2016-09-30 | 20 Years2006-09-25 | 30 Years1996-10-01 | All Time2003-01-10 |
|---|---|---|---|---|---|---|---|
| Price | $ 4.88 | $ 6.40 | $ 9.96 | $ 1.68 | $ 0.01 | $ 0.12 | $ 0.01 |
| Return | — | -23.75% | -51.00% | 190.48% | 325x | 41x | 325x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 60M | -$ 1M | $ 4M |
| 2026 | $ 59M | -$ 1M | $ 4M |
| 2025 | $ 56M | $ 4M | $ 9M |
| 2024 | $ 50M | -$ 7M | $ 2M |
| 2023 | $ 53M | -$ 5M | $ 10M |
| 2022 | $ 49M | $ 548K | $ 9M |
| 2021 | $ 41M | $ 362K | $ 4M |
| 2020 | $ 32M | -$ 2M | $ 8M |
| 2019 | $ 27M | $ 128K | $ 3M |
| 2018 | $ 20M | -$ 1M | $ 856K |
| 2017 | $ 15M | -$ 6M | $ 3M |
| 2016 | $ 11M | -$ 10M | $ 2M |
| 2015 | $ 8M | -$ 13M | $ 9M |
| 2014 | $ 11M | -$ 7M | $ 5M |
| 2013 | $ 8M | -$ 6M | $ 9M |
| 2012 | $ 7M | -$ 8M | $ 4M |
| 2011 | $ 6M | -$ 3M | $ 10M |
| 2010 | $ 4M | -$ 2M | $ 2M |
| 2009 | $ 3M | -$ 2M | $ 2M |
| 2008 | $ 1M | -$ 411K | $ 3M |
| 2007 | -$ 170.06K | $ 3.76K | |
| 2006 | -$ 303.72K | $ 540.00 | |
| 2005 | $ 1M | -$ 246.54K | $ 84.51K |
| 2004 | $ 1M | -$ 107.69K | $ 120.12K |
| IPO2003 | $ 2M | -$ 145.99K | $ 195.1K |
Champions Oncology Inc fundamental performance
Between 2016 and 2026, revenue grew from $ 11M to $ 59M and net income went from -$ 10M to -$ 1M. Revenue increased in 9 of those 10 years; net income in 6.
Across Champions Oncology Inc's full reported history, from 2003 to 2026, revenue grew from $ 2M to $ 59M and net income went from -$ 145.99K to -$ 1M. Revenue increased in 81% of the years measured; net income in 46%.
Champions Oncology Inc currently holds a 5-year HDB Score of 3.8 out of 10. How the HDB Score is calculated.
Membership
Continue CSBR’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,813 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
